The successful treatment of a 7-month-old infant with shunt-associated ventriculitis caused by vancomycin-resistant Enterococcus faecium is presented. Linezolid was administered intravenously ...

has led to the global emergence of an almost untreatable form of the antimicrobial resistant superbug vancomycin-resistant enterococcus faecium (VRE), which frequently causes serious infections in ...

CONCLUSIONS: Use of daptomycin in neutropenic patients with VRE BSI deserves further study as a treatment for VRE BSI in neutropenic patients.

A new study led by the University of Melbourne reveals that the antibiotic rifaximin contributes to the rise of vancomycin-resistant enterococcus faecium (VRE) and threatens its treatment with ...

The antibiotic, rifaximin, has enabled the global emergence of vancomycin-resistant enterococcus faecium, or VRE, a superbug that frequently causes serious ... use of rifaximin is driving bacterial ...

The antibiotic, rifaximin, has enabled the global emergence of vancomycin-resistant enterococcus faecium ... one of the last effective treatment options against VRE infections.